OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
Yefang Lao, Daoming Shen, Weili Zhang, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3575-3575
Open Access | Times Cited: 52
Yefang Lao, Daoming Shen, Weili Zhang, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3575-3575
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
Cancer immune escape: the role of antigen presentation machinery
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 64
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 64
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Peijie Wu, Jun Han, Yanju Gong, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 43
Peijie Wu, Jun Han, Yanju Gong, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 43
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 24
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 24
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Novel Strategies in Breast Cancer Management: from Treatment to Long-term Remission
S Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104715-104715
Closed Access | Times Cited: 1
S Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104715-104715
Closed Access | Times Cited: 1
Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Ion Negură, Mariana Pavel, Mihai Danciu
Cancer Treatment Reviews (2023) Vol. 120, pp. 102629-102629
Closed Access | Times Cited: 20
Ion Negură, Mariana Pavel, Mihai Danciu
Cancer Treatment Reviews (2023) Vol. 120, pp. 102629-102629
Closed Access | Times Cited: 20
Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse events
Seyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 18
Seyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 18
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 6
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 6
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 14
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 14
Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review
Nan Yao, Wenqiang Li, Ning Duan, et al.
Medicine (2024) Vol. 103, Iss. 2, pp. e36957-e36957
Open Access | Times Cited: 5
Nan Yao, Wenqiang Li, Ning Duan, et al.
Medicine (2024) Vol. 103, Iss. 2, pp. e36957-e36957
Open Access | Times Cited: 5
Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 5
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 5
Precision medicine in breast cancer (Review)
Petros Papalexis, Vasiliki Georgakopoulou, Panagiotis Drossos, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 5
Open Access | Times Cited: 5
Petros Papalexis, Vasiliki Georgakopoulou, Panagiotis Drossos, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 5
Open Access | Times Cited: 5
Application of Nanotechnology and Phytochemicals in Anticancer Therapy
Jin Hee Kim, Boluwatife Olamide Dareowolabi, Rekha Thiruvengadam, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1169-1169
Open Access | Times Cited: 5
Jin Hee Kim, Boluwatife Olamide Dareowolabi, Rekha Thiruvengadam, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1169-1169
Open Access | Times Cited: 5
Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37376-e37376
Open Access | Times Cited: 4
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37376-e37376
Open Access | Times Cited: 4
Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 3, pp. 881-881
Open Access | Times Cited: 10
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 3, pp. 881-881
Open Access | Times Cited: 10
Benefits of a diverse gut microbiome in systemic anti-cancer therapy patients
Beth Pantlin
British Journal of Nursing (2025) Vol. 34, Iss. 1, pp. 8-12
Closed Access
Beth Pantlin
British Journal of Nursing (2025) Vol. 34, Iss. 1, pp. 8-12
Closed Access
In Vitro Evaluation of the Safety and Efficacy of Cibisatamab Using Adult Stem Cell-Derived Organoids and Colorectal Cancer Spheroids
Victor Anstett, Elisa Heinzelmann, Francesco Piraino, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 291-291
Open Access
Victor Anstett, Elisa Heinzelmann, Francesco Piraino, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 291-291
Open Access
Role of T-cells in immunotherapy of pancreatic and colon cancers
Ashni Dudhia, Mia Rajan, Keshav Patel, et al.
Elsevier eBooks (2025), pp. 233-244
Closed Access
Ashni Dudhia, Mia Rajan, Keshav Patel, et al.
Elsevier eBooks (2025), pp. 233-244
Closed Access
Recent development in treatment strategies for breast cancer: With special reference to immunotherapy
Riya Sharma, Jaishree Karnwal Tiwari, Parvesh Kumari, et al.
Elsevier eBooks (2025), pp. 131-147
Closed Access
Riya Sharma, Jaishree Karnwal Tiwari, Parvesh Kumari, et al.
Elsevier eBooks (2025), pp. 131-147
Closed Access
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Properties of Monocyte-Derived Dendritic Cells Loaded With Lysates of Cancer Cells Exposed to Cytotoxic Peptides
N. Khranovska, O. Skachkova, О. Gorbach, et al.
Experimental Oncology (2025) Vol. 46, Iss. 4, pp. 375-386
Closed Access
N. Khranovska, O. Skachkova, О. Gorbach, et al.
Experimental Oncology (2025) Vol. 46, Iss. 4, pp. 375-386
Closed Access
Exploring radiation resistance-related genes in pancreatic cancer and their impact on patient prognosis and treatment
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Saud Almawash
Cancers (2025) Vol. 17, Iss. 5, pp. 880-880
Open Access
Saud Almawash
Cancers (2025) Vol. 17, Iss. 5, pp. 880-880
Open Access
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
